Dallah Healthcare Management
Management criteria checks 1/4
Dallah Healthcare's CEO is Ahmad bin Babaeer, appointed in Apr 2021, has a tenure of 3.67 years. directly owns 0.002% of the company’s shares, worth SAR291.27K. The average tenure of the management team and the board of directors is 2.4 years and 2.1 years respectively.
Key information
Ahmad bin Babaeer
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 3.7yrs |
| CEO ownership | 0.002% |
| Management average tenure | 2.4yrs |
| Board average tenure | 2.1yrs |
Recent management updates
Recent updates
With EPS Growth And More, Dallah Healthcare (TADAWUL:4004) Makes An Interesting Case
Dec 21
Some Shareholders Feeling Restless Over Dallah Healthcare Company's (TADAWUL:4004) P/E Ratio
Oct 31The Return Trends At Dallah Healthcare (TADAWUL:4004) Look Promising
Oct 07Do Dallah Healthcare's (TADAWUL:4004) Earnings Warrant Your Attention?
Sep 19Dallah Healthcare Company (TADAWUL:4004) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year
Aug 14The Price Is Right For Dallah Healthcare Company (TADAWUL:4004)
Jul 18Investors Will Want Dallah Healthcare's (TADAWUL:4004) Growth In ROCE To Persist
May 30We Ran A Stock Scan For Earnings Growth And Dallah Healthcare (TADAWUL:4004) Passed With Ease
Apr 16What You Can Learn From Dallah Healthcare Company's (TADAWUL:4004) P/E
Mar 18Returns On Capital At Dallah Healthcare (TADAWUL:4004) Have Hit The Brakes
Feb 25Dallah Healthcare (TADAWUL:4004) Has More To Do To Multiply In Value Going Forward
Oct 30Dallah Healthcare (TADAWUL:4004) Is Reinvesting At Lower Rates Of Return
Jul 26Returns On Capital Signal Tricky Times Ahead For Dallah Healthcare (TADAWUL:4004)
Apr 17Is Now The Time To Put Dallah Healthcare (TADAWUL:4004) On Your Watchlist?
Feb 06Dallah Healthcare (TADAWUL:4004) Will Want To Turn Around Its Return Trends
Dec 05We Ran A Stock Scan For Earnings Growth And Dallah Healthcare (TADAWUL:4004) Passed With Ease
Nov 01Calculating The Intrinsic Value Of Dallah Healthcare Company (TADAWUL:4004)
Aug 28Dallah Healthcare (TADAWUL:4004) Has Some Way To Go To Become A Multi-Bagger
Aug 12Here's Why We Think Dallah Healthcare (TADAWUL:4004) Is Well Worth Watching
Jul 28Industry Analysts Just Upgraded Their Dallah Healthcare Company (TADAWUL:4004) Revenue Forecasts By 10%
May 26Calculating The Fair Value Of Dallah Healthcare Company (TADAWUL:4004)
May 20Here's Why We Think Dallah Healthcare (TADAWUL:4004) Is Well Worth Watching
Apr 16Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively
Feb 03Is Now The Time To Put Dallah Healthcare (TADAWUL:4004) On Your Watchlist?
Jan 10Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively
Oct 19Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively
Jul 09Forecast: Analysts Think Dallah Healthcare Company's (TADAWUL:4004) Business Prospects Have Improved Drastically
Jun 16Broker Revenue Forecasts For Dallah Healthcare Company (TADAWUL:4004) Are Surging Higher
May 02What Kind Of Shareholders Hold The Majority In Dallah Healthcare Company's (TADAWUL:4004) Shares?
Mar 17Has Dallah Healthcare (TADAWUL:4004) Got What It Takes To Become A Multi-Bagger?
Mar 02Dallah Healthcare (TADAWUL:4004) Shareholders Booked A 45% Gain In The Last Year
Feb 15Should You Buy Dallah Healthcare Company (TADAWUL:4004) For Its Dividend?
Feb 01Are Dallah Healthcare's (TADAWUL:4004) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Jan 05
Dallah Healthcare Company's (TADAWUL:4004) Intrinsic Value Is Potentially 26% Below Its Share Price
Dec 22Will Dallah Healthcare (TADAWUL:4004) Multiply In Value Going Forward?
Nov 20CEO
Ahmad bin Babaeer (66 yo)
3.7yrs
Tenure
ر.س8,000
Compensation
Dr. Ahmad bin Saleh Babaeer serves as the Chief Executive Officer of Dallah Healthcare Company since April 2021. Dr. Babaeer served as General Manager of Dallah Hospital at Dallah Healthcare Holding Co. Dr...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Director & General Medical Supervisor | no data | ر.س2.89m | 4.84% SAR 719.9m | |
| Chief Executive Officer | 3.7yrs | ر.س8.00k | 0.0020% SAR 291.3k | |
| Chief Financial Officer | 2.9yrs | no data | no data | |
| Chief Operating Officer | no data | no data | no data | |
| Chief Medical Officer | 7.9yrs | no data | no data | |
| C.S.O. | 1.8yrs | no data | no data | |
| Chief Commercial Officer | 1.9yrs | no data | no data | |
| Chief Digitization Officer | less than a year | no data | no data |
2.4yrs
Average Tenure
71yo
Average Age
Experienced Management: 4004's management team is considered experienced (2.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Director & General Medical Supervisor | no data | ر.س2.89m | 4.84% SAR 719.9m | |
| Chairman of the Board | 11.2yrs | ر.س2.23m | 4.84% SAR 719.9m | |
| Vice Chairman of the Board | 2.1yrs | ر.س329.60k | 0.0016% SAR 233.3k | |
| Director | no data | ر.س413.33k | no data | |
| Director | no data | ر.س321.00k | no data | |
| Independent Director | 3.9yrs | ر.س347.00k | no data | |
| Director | 2.1yrs | no data | no data | |
| Director | 2.1yrs | no data | no data | |
| Director | 1.8yrs | no data | no data |
2.1yrs
Average Tenure
60.5yo
Average Age
Experienced Board: 4004's board of directors are not considered experienced ( 2.1 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 07:22 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Dallah Healthcare Company is covered by 22 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ibrahim Elaiwat | Aljazira Capital Company |
| Jassim Al-Jubran | Aljazira Capital Company |
| Rim Ben Salah Gharbi | AlphaMena |